Literature DB >> 26114869

Are Adiponectin and Leptin Good Predictors of Surgical Infection after Colorectal Surgery? A Prospective Study.

Pablo Ortega-Deballon1,2, Louise Ménégaut3, Isabelle Fournel4, David Orry5, David Masson3,2, Christine Binquet4,2, Olivier Facy1,2.   

Abstract

BACKGROUND: Infections are the most frequent complication after colorectal surgery. It has been suggested that adipose tissue metabolism could be related to the risk of post-operative infection, but this could be partially related to the body-mass index. The aim of this study was to look for a relation between adipocytokine levels and the risk of post-operative infection and its type.
METHODS: This prospective cohort study was conducted between March 2013 and March 2014 in two French teaching hospitals. Pre-operative plasma levels of adiponectin and leptin were measured in consecutive patients undergoing elective colorectal surgery. All infections in the 30 d following surgery were recorded.
RESULTS: Among the 142 patients included, 29 (20.4%) presented a post-operative infection: 26 surgical site infections and three extra-abdominal infections. Adiponectin and leptin levels correlated weakly but substantially with the body mass index (rspearman=-0.26 and +0.31, respectively). While there was no substantial difference between patients with and those without post-operative infection for adiponectin, median pre-operative leptin was substantially greater in patients with post-operative infection (8.67 vs. 4.37 ng/mL, p=0.003). A substantial interaction was found between leptin and cancer. In patients operated on for cancer, the area under the receiver-operating characteristic (ROC) curve was lower than in patients with benign diseases (0.597 vs. 0.858, p=0.011). Similar results were observed for intra-abdominal infection and surgical site infection.
CONCLUSION: Patients with greater levels of leptin before colorectal surgery have an increased risk of post-operative surgical infection. This effect is stronger in patients without cancer. Adiponectin levels are not related to the risk of infection in Western patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26114869     DOI: 10.1089/sur.2014.206

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  4 in total

1.  Preoperative inflammation increases the risk of infection after elective colorectal surgery: results from a prospective cohort.

Authors:  Luigi De Magistris; Brice Paquette; David Orry; Olivier Facy; Giovanni Di Giacomo; Patrick Rat; Christine Binquet; Pablo Ortega-Deballon
Journal:  Int J Colorectal Dis       Date:  2016-06-29       Impact factor: 2.571

2.  Local perivascular adiponectin associates with lower extremity vascular operative wound complications.

Authors:  Gaurav Sharma; Rohan Kulkarni; Samir K Shah; William W King; Alban Longchamp; Ming Tao; Kui Ding; C Keith Ozaki
Journal:  Surgery       Date:  2016-04-14       Impact factor: 3.982

3.  Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer.

Authors:  David P J van Dijk; Maikel J A M Bakens; Mariëlle M E Coolsen; Sander S Rensen; Ronald M van Dam; Martijn J L Bours; Matty P Weijenberg; Cornelis H C Dejong; Steven W M Olde Damink
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-10-26       Impact factor: 12.910

4.  Benefit of a flash dose of corticosteroids in digestive surgical oncology: a multicenter, randomized, double blind, placebo-controlled trial (CORTIFRENCH).

Authors:  Joséphine Magnin; Isabelle Fournel; Alexandre Doussot; Jean-Marc Régimbeau; Philippe Zerbib; Guillaume Piessen; Laura Beyer-Berjot; Sophie Deguelte; Zaher Lakkis; Lilian Schwarz; David Orry; Ahmet Ayav; Fabrice Muscari; François Mauvais; Guillaume Passot; Nelson Trelles; Aurélien Venara; Stéphane Benoist; Mathieu Messager; David Fuks; Baptiste Borraccino; Christophe Trésallet; Alain Valverde; François-Régis Souche; Astrid Herrero; Sébastien Gaujoux; Jérémie Lefevre; Abderrahmane Bourredjem; Amélie Cransac; Pablo Ortega-Deballon
Journal:  BMC Cancer       Date:  2022-08-23       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.